ロード中...
Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses
PURPOSE: Oral metronidazole therapy is the standard of care for bacterial vaginosis (BV), yet it has alarming rates of recurrence and refractory responses among recurrent BV (RBV) patients. This study addresses whether high dose vaginal metronidazole therapy (HDM) is beneficial in RBV patients who f...
保存先:
| 出版年: | Infect Drug Resist |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6661983/ https://ncbi.nlm.nih.gov/pubmed/31413606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S213853 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|